These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 26738867)
1. Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma. Chen YJ; Zhao RM; Zhao Q; Li BY; Ma QY; Li X; Chen X Tumour Biol; 2016 Jul; 37(7):8715-20. PubMed ID: 26738867 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules. Mai KT; Ford JC; Yazdi HM; Perkins DG; Commons AS Pathol Res Pract; 2000; 196(8):533-40. PubMed ID: 10982016 [TBL] [Abstract][Full Text] [Related]
3. Roles of phosphatidylinositol 3-kinase regulatory subunit alpha, activator protein-1, and programmed cell death 4 in diagnosis of papillary thyroid carcinoma. Chen X; Wu W; Chen X; Gong X Tumour Biol; 2016 May; 37(5):6519-26. PubMed ID: 26637226 [TBL] [Abstract][Full Text] [Related]
4. Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma: improvement in the sensitivity or specificity? Wu G; Wang J; Zhou Z; Li T; Tang F J Int Med Res; 2013 Aug; 41(4):975-83. PubMed ID: 23857157 [TBL] [Abstract][Full Text] [Related]
5. TROP-2 expression in papillary thyroid cancer: a preliminary cyto-histological study. Addati T; Achille G; Centrone M; Petroni S; Popescu O; Russo S; Grammatica L; Simone G Cytopathology; 2015 Oct; 26(5):303-11. PubMed ID: 25164548 [TBL] [Abstract][Full Text] [Related]
6. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1. Jianming L; Jibin L; Linxue Q Eur J Radiol; 2020 Feb; 123():108801. PubMed ID: 31918249 [TBL] [Abstract][Full Text] [Related]
7. Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV. de Micco C; Savchenko V; Giorgi R; Sebag F; Henry JF Br J Cancer; 2008 Feb; 98(4):818-23. PubMed ID: 18212751 [TBL] [Abstract][Full Text] [Related]
8. The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology. Bizzarro T; Martini M; Marrocco C; D'Amato D; Traini E; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM; Rossi ED PLoS One; 2015; 10(7):e0132939. PubMed ID: 26186733 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules. Abd-El Raouf SM; Ibrahim TR Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance. Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646 [TBL] [Abstract][Full Text] [Related]
12. Paired box gene 8, HBME-1, and cytokeratin 19 expression in preoperative fine-needle aspiration of papillary thyroid carcinoma: diagnostic utility. Schmitt AC; Cohen C; Siddiqui MT Cancer Cytopathol; 2010 Aug; 118(4):196-202. PubMed ID: 20731005 [TBL] [Abstract][Full Text] [Related]
13. Contribution of immunocytochemical stainings for galectin-3, CD44, and HBME1 to fine-needle aspiration cytology diagnosis of papillary thyroid carcinoma. Das DK; Al-Waheeb SK; George SS; Haji BI; Mallik MK Diagn Cytopathol; 2014 Jun; 42(6):498-505. PubMed ID: 24273003 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma. Zhu X; Sun T; Lu H; Zhou X; Lu Y; Cai X; Zhu X J Clin Pathol; 2010 Sep; 63(9):786-9. PubMed ID: 20644217 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of HBME-1, CD56, Galectin-3 and Cytokeratin-19 in papillary thyroid carcinomas and thyroid tumors of uncertain malignant potential. Nechifor-Boilă A; Cătană R; Loghin A; Radu TG; Borda A Rom J Morphol Embryol; 2014; 55(1):49-56. PubMed ID: 24715165 [TBL] [Abstract][Full Text] [Related]
17. HBME-1 expression in hyalinizing trabecular tumours of the thyroid gland. Lenggenhager D; Maggio EM; Moch H; Rössle M Histopathology; 2013 Jun; 62(7):1092-7. PubMed ID: 23617709 [TBL] [Abstract][Full Text] [Related]
18. TROP-2 immunohistochemistry: a highly accurate method in the differential diagnosis of papillary thyroid carcinoma. Bychkov A; Sampatanukul P; Shuangshoti S; Keelawat S Pathology; 2016 Aug; 48(5):425-33. PubMed ID: 27311870 [TBL] [Abstract][Full Text] [Related]
19. Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma. Liu YY; Morreau H; Kievit J; Romijn JA; Carrasco N; Smit JW Eur J Endocrinol; 2008 Mar; 158(3):375-84. PubMed ID: 18299472 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma. Zhang M; Wu W; Gao M; Fei Z Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]